S
2.85
0.07 (2.52%)
| Penutupan Terdahulu | 2.78 |
| Buka | 2.79 |
| Jumlah Dagangan | 2,716,210 |
| Purata Dagangan (3B) | 1,466,740 |
| Modal Pasaran | 636,316,608 |
| Harga / Buku (P/B) | 1.30 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 26 Feb 2025 - 3 Mar 2025 |
| EPS Cair (TTM) | -1.40 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 32.85% |
| Nisbah Semasa (MRQ) | 4.47 |
| Aliran Tunai Operasi (OCF TTM) | -227.95 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -187.32 M |
| Pulangan Atas Aset (ROA TTM) | -31.15% |
| Pulangan Atas Ekuiti (ROE TTM) | -92.90% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | Sana Biotechnology, Inc. | Menurun | Bercampur |
AISkor Stockmoo
-0.2
| Konsensus Penganalisis | -0.5 |
| Aktiviti Orang Dalam | -3.0 |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -0.5 |
| Purata | -0.20 |
|
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 among others. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 8.63% |
| % Dimiliki oleh Institusi | 92.46% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Crestline Management, Lp | 30 Sep 2024 | 3,085,624 |
| Julat 52 Minggu | ||
| Median | 8.00 (180.70%) | |
| Jumlah | 1 Beli | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| HC Wainwright & Co. | 27 Nov 2024 | 8.00 (180.70%) | Beli | 2.55 |
| 11 Nov 2024 | 8.00 (180.70%) | Beli | 2.89 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| WYRICK SUSAN D. | - | 1.65 | -1,566 | -2,584 |
| Jumlah Keseluruhan Kuantiti Bersih | -1,566 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -2,584 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 1.65 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| WYRICK SUSAN D. | Pegawai | 02 Jan 2025 | Dibuang (-) | 1,566 | 1.65 | 2,584 |
| WYRICK SUSAN D. | Pegawai | 02 Jan 2025 | Pelaksanaan pilihan | 5,000 | - | - |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |